https://hal-univ-rennes1.archives-ouvertes.fr/hal-01300794
Contributor : Laurent Jonchère <>
Submitted on : Monday, April 11, 2016 - 2:14:42 PM Last modification on : Thursday, January 14, 2021 - 11:23:52 AM
Mark S. Freedman, Ludwig Kappos, Gilles Edan, Xavier Montalban, Hans-Peter Hartung, et al.. Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11). Multiple Sclerosis Journal, SAGE Publications, 2016, 22, pp.19--20. ⟨hal-01300794⟩